These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 16024783

  • 1. Convergent actions of I kappa B kinase beta and protein kinase C delta modulate mRNA stability through phosphorylation of 14-3-3 beta complexed with tristetraprolin.
    Gringhuis SI, García-Vallejo JJ, van Het Hof B, van Dijk W.
    Mol Cell Biol; 2005 Aug; 25(15):6454-63. PubMed ID: 16024783
    [Abstract] [Full Text] [Related]

  • 2. Structure/function analysis of tristetraprolin (TTP): p38 stress-activated protein kinase and lipopolysaccharide stimulation do not alter TTP function.
    Rigby WF, Roy K, Collins J, Rigby S, Connolly JE, Bloch DB, Brooks SA.
    J Immunol; 2005 Jun 15; 174(12):7883-93. PubMed ID: 15944294
    [Abstract] [Full Text] [Related]

  • 3. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element.
    Hitti E, Iakovleva T, Brook M, Deppenmeier S, Gruber AD, Radzioch D, Clark AR, Blackshear PJ, Kotlyarov A, Gaestel M.
    Mol Cell Biol; 2006 Mar 15; 26(6):2399-407. PubMed ID: 16508014
    [Abstract] [Full Text] [Related]

  • 4. Mitogen-activated protein kinase p38 controls the expression and posttranslational modification of tristetraprolin, a regulator of tumor necrosis factor alpha mRNA stability.
    Mahtani KR, Brook M, Dean JL, Sully G, Saklatvala J, Clark AR.
    Mol Cell Biol; 2001 Oct 15; 21(19):6461-9. PubMed ID: 11533235
    [Abstract] [Full Text] [Related]

  • 5. MAPKAP kinase 2 blocks tristetraprolin-directed mRNA decay by inhibiting CAF1 deadenylase recruitment.
    Marchese FP, Aubareda A, Tudor C, Saklatvala J, Clark AR, Dean JL.
    J Biol Chem; 2010 Sep 03; 285(36):27590-600. PubMed ID: 20595389
    [Abstract] [Full Text] [Related]

  • 6. MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay.
    Stoecklin G, Stubbs T, Kedersha N, Wax S, Rigby WF, Blackwell TK, Anderson P.
    EMBO J; 2004 Mar 24; 23(6):1313-24. PubMed ID: 15014438
    [Abstract] [Full Text] [Related]

  • 7. Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment.
    Clement SL, Scheckel C, Stoecklin G, Lykke-Andersen J.
    Mol Cell Biol; 2011 Jan 24; 31(2):256-66. PubMed ID: 21078877
    [Abstract] [Full Text] [Related]

  • 8. The role of mRNA turnover in the regulation of tristetraprolin expression: evidence for an extracellular signal-regulated kinase-specific, AU-rich element-dependent, autoregulatory pathway.
    Brooks SA, Connolly JE, Rigby WF.
    J Immunol; 2004 Jun 15; 172(12):7263-71. PubMed ID: 15187101
    [Abstract] [Full Text] [Related]

  • 9. Expression, purification, and biochemical characterization of the antiinflammatory tristetraprolin: a zinc-dependent mRNA binding protein affected by posttranslational modifications.
    Cao H.
    Biochemistry; 2004 Nov 02; 43(43):13724-38. PubMed ID: 15504035
    [Abstract] [Full Text] [Related]

  • 10. Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA.
    Sun L, Stoecklin G, Van Way S, Hinkovska-Galcheva V, Guo RF, Anderson P, Shanley TP.
    J Biol Chem; 2007 Feb 09; 282(6):3766-77. PubMed ID: 17170118
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhibition of protein kinase Cdelta reduces tristetraprolin expression by destabilizing its mRNA in activated macrophages.
    Leppänen T, Jalonen U, Korhonen R, Tuominen RK, Moilanen E.
    Eur J Pharmacol; 2010 Feb 25; 628(1-3):220-5. PubMed ID: 19925787
    [Abstract] [Full Text] [Related]

  • 16. Control of mRNA decay by phosphorylation of tristetraprolin.
    Sandler H, Stoecklin G.
    Biochem Soc Trans; 2008 Jun 25; 36(Pt 3):491-6. PubMed ID: 18481987
    [Abstract] [Full Text] [Related]

  • 17. Tristetraprolin regulates Cyclin D1 and c-Myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling.
    Marderosian M, Sharma A, Funk AP, Vartanian R, Masri J, Jo OD, Gera JF.
    Oncogene; 2006 Oct 12; 25(47):6277-90. PubMed ID: 16702957
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA.
    Stoecklin G, Gross B, Ming XF, Moroni C.
    Oncogene; 2003 Jun 05; 22(23):3554-61. PubMed ID: 12789264
    [Abstract] [Full Text] [Related]

  • 20. CNOT7/hCAF1 is involved in ICAM-1 and IL-8 regulation by tristetraprolin.
    Shi JX, Li JS, Hu R, Shi Y, Su X, Li Q, Zhang F.
    Cell Signal; 2014 Nov 05; 26(11):2390-6. PubMed ID: 25038453
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.